In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...

AstraZeneca to acquire EsoBiotec to advance cell therapy ambition Acquisition includes world-leading in vivo delivery platform with potential to transform cell therapy AstraZeneca has ...

Residents of Badiyadka village in Kasaragod have raised Rs. 42 lakh for Prashanth Rai, a Hindi teacher battling blood cancer.

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell ...

The batteries will be recyclable, in keeping with the Embleme’s philosophy – half of the concept’s materials are recycled and the carbon footprint of its components reduced by 70 per cent. This is an ...

Researchers, including those from the Indian Institute of Technology-Bombay and Tata Memorial Hospital, Mumbai, said in low ...

An indigenously developed CAR T-cell gene therapy has achieved a 73% response rate for certain blood cancers in India. The ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

The fuel gauge showed just a tiny amount of hydrogen in the vehicle’s tank, and someone on the sales staff at Roseville ...

Electric cars have soared in popularity in the wake of high gasoline prices. While improvements in vehicle battery technology ...

Precision Biosciences' ARCUS platform offers high precision and versatility, supporting in vivo gene editing therapies, and ...

My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...